logo
    • English
      • 简体中文
      • 繁體中文
  • Home
  • Articles
    • Insights
    • Client Press Releases
    • Client Coverage
  • Interviews
    • CEO Interview
    • PDAC Interview
  • Clients
    • Featured Companies
    • In-depth Analysis
  • Markets
    • Stock Tracker
    • Markets at a glance
    • Investing 101
      • Investing in Mining 101
        • Gold and Precious Metals
        • Electric and Battery Metals
        • Base Metals
        • Other Mining Subsectors
  • METALS 100
  • GCFF Event
    • Next Event
    • Past Events
  • Home
  • Trends & Strategies
  • Life Science & Technology Weekly 129 – Two monkeys were cloned in China to help with cancer research

Life Science & Technology Weekly 129 – Two monkeys were cloned in China to help with cancer research

NAI Life Science Weekly - www.nai500.com
Published on: Jan 25, 2018
Author: Editor
  • Share article:

Check www.nai500.com for more investment opportunities

Click here to find more details

This is NAI’s new Life Science and Technology Weekly. We will be covering the latest news in life science, pharmaceutical, biotech and technology sectors every week. To continue to receive NAI’s Life Science and Technology Weekly, please click Here to subscribe.

Biotechnology Life Science Medical Device Pharmaceutical Technology

Related Posts

ASML Leads the AI Memory Cycle as Samsung and TSMC Race for High-NA Tools

ASML Leads the AI Memory Cycle as Samsung and TSMC Race for High-NA Tools

秃发患者的曙光?艾伯维新药让过半患者头皮毛发再生超80%

AbbVie’s Diversification Bet Gradually Shows Results, While Pfizer Seeks a Second Takeoff Through Its GLP-1 and Oncology Pipelines

多重利好因素下,台积电股价上涨近5%

TSMC’s Market Share Exceeds 70 Percent, Making It Irreplaceable, and Analysts Believe the Current Pullback Offers a Buying Opportunity

U.S. Launches ‘Prometheus’ AI Nuclear Initiative, With X-Energy, Oklo Among Partners

Restaurant Order Automation Drives High Growth: Can SoundHound AI Return to Its Peak?

Moderna’s 5x Surge Just Hit a Wall. Time to Buy or Bail?

Moderna’s 5x Surge Just Hit a Wall. Time to Buy or Bail?

OpenAI Declares the AGI Era, but This Risk Cannot Be Ignored

OpenAI Declares the AGI Era, but This Risk Cannot Be Ignored

Related News

Bloom Energy Cracks the S&P 500: Speed, Backlog, and a $25 Billion Backer

4 hours ago.

ASML Leads the AI Memory Cycle as Samsung and TSMC Race for High-NA Tools

5 hours ago.

AbbVie’s Diversification Bet Gradually Shows Results, While Pfizer Seeks a Second Takeoff Through Its GLP-1 and Oncology Pipelines

3 days ago.

TSMC’s Market Share Exceeds 70 Percent, Making It Irreplaceable, and Analysts Believe the Current Pullback Offers a Buying Opportunity

3 days ago.

Top Stories

ASML Leads the AI Memory Cycle as Samsung and TSMC Race for High-NA Tools
Technology

ASML Leads the AI Memory Cycle as Samsung and TSMC Race for High-NA Tools

Tesla Gives Back All Its Gains as Cybercab Launch Raises More Questions Than Answers
Technology

Tesla Gives Back All Its Gains as Cybercab Launch Raises More Questions Than Answers

We connect Investors to Opportunities.

Financial Market Data copyright © 2020 QuoteMedia. Data delayed 15 minutes unless otherwise indicated (view delay times for all exchanges). RT=Real-Time, EOD=End of Day, PD=Previous Day. Market Data powered by QuoteMedia. Terms of Use.

 
QuoteMedia logo

Head Office

  • 2209 – 1111 Alberni Street
    Vancouver, BC Canada V6E 4V2
  • Phone: (604) 488-8878
  • Fax: (604) 488-0868
  • Toll Free: 1 (866) 833-5517
  • Email: [email protected]

Shanghai Office

  • 06 - 607, 6/f. No.800 Shangcheng
    Road Pudong New District Shanghai,
    China
  • Phone: 021-68883919
  • Fax: 021-68882879
  • Email: [email protected]

Important Links

  • Privacy Policy
  • Terms of Use
  • Content Partner
  • NAI500 Investor Relations Services
  • About Us
  • Contact Us

© 2026 NAI Interactive Ltd. All Rights Reserved

gcff

logo

Website Design Vancouver by Nirvana Canada